Position in LLY
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$343,341,662
+$92,708,020 QoQ
Shares Held
286,254
+5.0% QoQ
Ownership
0.030%
of shares outstanding
% of Portfolio
0.75%
of 13F equity value
Holder Rank
#195
of 4,621 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Mirae Asset Global Investments Co., Ltd. holds $1,549,695,317 across 14 Drug Manufacturers - General names. LLY ranks #1 (22.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
286,254 | $343,341,662 | |
| 2 | AMGN |
Amgen Inc
|
785,516 | $284,451,053 | |
| 3 | MRK |
Merck & Co., Inc.
|
2,033,072 | $261,249,751 | |
| 4 | JNJ |
Johnson & Johnson
|
718,900 | $182,579,032 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
2,396,422 | $138,081,835 | |
| 6 | ABBV |
AbbVie Inc.
|
495,003 | $124,562,554 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
926,242 | $117,021,414 | |
| 8 | PFE |
Pfizer Inc
|
1,539,905 | $37,080,912 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $343,341,662 | 286,254 | Shares | Defined | 2026-07-22 | |
| 2026-03-31 | $250,633,642 | 272,496 | Shares | Defined | 2026-05-04 | |
| 2025-12-31 | $298,490,247 | 277,748 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $190,458,534 | 249,618 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $182,884,752 | 234,609 | Shares | Sole | 2025-07-21 | |
| 2025-03-31 | $199,263,023 | 797,927 | Shares | Defined | 2025-04-24 | |
| 2024-12-31 | $218,204,256 | 282,648 | Shares | Defined | 2025-01-27 | |
| 2024-09-30 | $252,410,506 | 284,907 | Shares | Defined | 2024-10-23 | |
| 2024-06-30 | $232,978,717 | 257,327 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $259,791,182 | 333,939 | Shares | Defined | 2024-05-01 | |
| 2023-12-31 | $173,847,726 | 298,236 | Shares | Defined | 2024-01-24 | |
| 2023-09-30 | $168,233,411 | 313,208 | Shares | Defined | 2023-10-26 | |
| 2023-06-30 | $154,076,812 | 328,536 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $137,972,760 | 401,761 | Shares | Defined | 2023-05-04 | |
| 2022-12-31 | $138,886,398 | 379,637 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $146,807,040 | 454,019 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $155,440,074 | 479,413 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $158,758,658 | 554,383 | Shares | Defined | 2022-05-10 | |
| 2021-12-31 | $179,947,383 | 651,464 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $149,821,829 | 648,439 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $111,340,380 | 485,101 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $94,247,700 | 504,484 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $20,112,556 | 119,122 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $17,016,525 | 114,961 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $11,293,611 | 68,788 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $9,394,671 | 67,724 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||